#Japan #Tokyo #pharmaceuticals #patent strategy #JPI

Overview of the Seminar

The Japan Planning Institute (JPI) is organizing an insightful seminar entitled "Core of Next-Generation IP Strategy Looking at the Global Market: Patent Strategies for Pharmaceutical Modalities". The session will be held on July 29, 2025, from 13:30 to 16:00 and will feature expert insights from Kato Hiroshi, a patent lawyer from the Aoyama Patent Office in Tokyo and the chairman of the Intellectual Property Graduate School Council.

Seminar Details

The growing research and development in pharmaceutical modalities such as antibody drugs, nucleic acid medicines, mid-sized molecular medicines, regenerative medicine, and cell therapy marks a significant shift towards commercialization. This seminar aims to address this evolution by unpacking the trends in patent application, patent examination, and relevant litigation cases associated with pharmaceutical modalities.

What to Expect

Kato will delve into:
1. Current Status and Challenges in Pharmaceutical Modalities
- Key developments in pharmaceutical modalities
- Directions for practical application

2. Trends in Patent Applications
- Antibody Drugs: Structural modifications, drug-antibody conjugates, bispecific antibodies
- Nucleic Acid Medicines: Structural alterations, nucleic acid-ligand complexes, lipid nanoparticles
- Low and Mid-Sized Molecular Medicines: Prodrugs, crystal polymorphs, and liposomes
- Regenerative and Cell Therapies: Lysosomes, organoids, immunotherapy, genome editing

3. Challenges in Patent Applications
- Timing and considerations for patent applications
- Necessary patent search considerations in R&D
- Integrating research and development strategies with patent strategies
- Future directions for R&D strategy

4. Practices in Pharmaceutical Patents
- Characteristics of strong patents
- Required level of inventiveness and data disclosure
- Strategies for responding to patent examination rejections

5. Recent Judicial Cases
- Newness requirements for nucleic acid patents: The Stuffer/Philar Polynucleotide Sequence Case
- Inventiveness in antibody cases: The PIVKA-II Antibody Case
- Progress requirements in medicinal inventions: The Polysaccharide-Protein Conjugate Case
- Progress requirements for treatment agents in inflammatory and autoimmune diseases

6. New Perspectives on Future Patent Strategies
- Trends in newly registered patents and their examination history
- Comparison of patent claims between Japan, US, and Europe, and Japan, China, and South Korea
- Proposals for optimal patent specification and claims
- Formulating patent strategies for pharmaceutical modalities

7. Q&A Session
8. Networking Event
This interactive session will allow participants to network with the instructor and fellow attendees, enhancing your professional connections for potential business expansion.

Attendance Options

Participants can choose between in-person attendance, live streaming, or accessing recorded content for up to two weeks.

Registration Fees

• - Individual: 37,220 JPY (tax included)
• - Group (from two or more individuals from the same company): 32,220 JPY

- Special rate for representatives from local public organizations: 11,000 JPY for up to two attendees, applicable only to in-person or live stream sessions.

Post Seminar Opportunities

Following the seminar, participants can ask questions or request introductions to the instructor. This fosters a valuable networking environment and aids in the creation of fresh business opportunities.

For further details and registration, please visit: JPI Seminar Registration.

Contact Information

Japan Planning Institute
Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo 106-0047
Phone: 03-5793-9761
Fax: 03-5793-9767
Website: www.jpi.co.jp

About JPI

For over half a century, JPI has acted as a bridge among government and private sectors, providing exclusive seminars aimed at enhancing the knowledge base necessary for senior management to support national policies and projects.